Work

Phase IIa trial of cilengitide (EMD121974) single-agent therapy in patients (pts) with recurrent glioblastoma (GBM): EMD 121974-009

Year: 2007

Type: conference-abstract

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.2007.25.18_suppl.2002

Authors: D. Reardon, K. Fink, B. Nabors, T. Cloughesy, S. Plotkin, D. Schiff, J. Raizer, S. Krueger, M. Picard, T. Mikkelsen

Institutions: Henry Ford Health, University of California, Los Angeles, University of Alabama, University of Alabama at Birmingham, Massachusetts General Hospital, Duke Medical Center, University of Virginia

Language: English

Topic: Glioma Diagnosis and Treatment

Subfield: Genetics

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W1785073076

Cites:

Cited by: 23

Related to: 10